Northstar Group, Inc. Amgen Inc Transaction History

Northstar Group, Inc.

$594 Million
Q4 2024

A detailed history of Northstar Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Northstar Group, Inc. holds 1,452 shares of AMGN stock, worth $430,750. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,452

Previous 1,435 1.18%

Holding current value

$430,750

Previous $462,000 18.18%

% of portfolio

0.06%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	BUY	$258.78 - $328.31 $4,399 - $5,581	17 Added 1.18%	1,452 $378,000
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $20,494 - $24,906	-78 Reduced 5.16%	1,435 $448,000
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $21,509 - $25,964	-80 Reduced 5.02%	1,513 $430,000
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $4,858 - $5,480	-19 Reduced 1.18%	1,593 $458,000
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $8,785 - $10,388	-41 Reduced 2.48%	1,612 $357,000
Q4 2022 Jan 25, 2023	SELL	$229.03 - $291.01 $20,612 - $26,190	-90 Reduced 5.16%	1,653 $0
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $20,763 - $23,106	-90 Reduced 4.91%	1,743 $424,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $13,758 - $16,033	62 Added 3.5%	1,833 $456,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $15,146 - $18,036	-70 Reduced 3.8%	1,771 $407,000
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $10,879 - $13,350	-55 Reduced 2.9%	1,841 $434,000
Q1 2020 May 04, 2020	SELL	$182.24 - $241.7 $34,625 - $45,923	-190 Reduced 9.11%	1,896 $384,000
Q4 2019 Jan 21, 2020	SELL	$189.21 - $243.2 $41,436 - $53,260	-219 Reduced 9.5%	2,086 $503,000
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $19,152 - $22,948	-110 Reduced 4.55%	2,305 $446,000
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $9,043 - $10,194	-50 Reduced 2.03%	2,415 $459,000
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $17,231 - $19,426	-93 Reduced 3.64%	2,465 $511,000
Q2 2018 Jul 27, 2018	SELL	$166.05 - $186.51 $8,302 - $9,325	-50 Reduced 1.92%	2,558 $472,000
Q1 2018 Apr 13, 2018	SELL	$169.43 - $198.0 $26,600 - $31,086	-157 Reduced 5.68%	2,608 $445,000
Q4 2017 Jan 23, 2018	BUY	$168.79 - $188.59 $8,439 - $9,429	50 Added 1.84%	2,765 $481,000
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $454,192 - $518,565	2,715	2,715 $506,000

Others Institutions Holding AMGN

# of Institutions

3,108

Shares Held

404M

Call Options Held

7.35M

Put Options Held

7.05M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $159B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northstar Group, Inc. with notifications on news.

Account

Northstar Group, Inc. Amgen Inc Transaction History